[Frontiers in Bioscience 7, d268-274, January 1, 2002] 268 PERSPECTIVES IN STUDIES OF HUMAN TUMOR VIRUSES
نویسنده
چکیده
Tumor viruses can be found in both the RNA and DNA virus kingdoms. All RNA tumor viruses belong to the retrovirus family. Directly transforming Class I RNA tumor viruses carry cellular oncogenes, picked up by accidental recombination, and usually selected for secondary modifications and high tumorigenicity by the investigator. They are not known to play any role for tumor causation in nature. Class II or chronic RNA tumor viruses do not carry cell-derived oncogenes but they often act by proviral DNA insertion into the immediate neighborhood of a cellular oncogene. Feline, murine, and avian leukemia viruses belong to this category. The human adult T-cell leukemia virus, (HTLV-1) and bovine leukemia virus (BLV) act by expanding the preneoplastic cell population and thereby provides the soil for secondary, cellular changes.
منابع مشابه
[Frontiers in Bioscience 7, d295-306, January 1, 2002] 295 MANIPULATION OF THE CELL CYCLE BY HUMAN CYTOMEGALOVIRUS
1. Abstract 2. Introduction 3. Human cytomegalovirus 4. Cell cycle 5. Virus effects on the cell cycle 6. Virus effects on cell cycle regulatory proteins 6.1. Rb tumor suppressor family 6.2. p53 tumor suppressor family 6.3. Oncogenes 6.4. Cyclins and cyclin regulators 6.4.1. Cyclin-dependent kinase inhibitors 6.4.2. Cyclins 6.4.3. Cyclin-dependent kinases 7. Viral proteins that alter cell cycle ...
متن کامل[Frontiers in Bioscience 8, s294-304, May 1, 2003] 294 PLASMINOGEN BINDING AND CANCER: PROMISES AND PITFALLS
1. Abstract 2. Introduction 3. Plasminogen conformation and activation: structure function relationships 4. Plasminogen binding to the cell surface 5. Mammalian cell surface plasminogen receptors 5.1. Multiple, distinct proteins may act as plasminogen receptors 5.2. A bona-fide receptor must be shown to be at the cell-surface 6. Regulation of plasminogen binding capacity is linked to uPAR-bound...
متن کامل[Frontiers in Bioscience 11, 804-817, January 1, 2006] 804 Viral Vectors for Cancer Immunotherapy
1. Abstract 2. Introduction 2.1. History and successes of cancer immunotherapy 2.2. Viruses and cancer therapy 3. Identification of tumor associated antigens 4. Ideal properties of an antigen delivery system 4.1. Why are viral vectors suitable for delivering TAAs? 5. Poxvirus vectors 5.1. Vaccinia virus 5.1.1. Use of vaccinia viral vectors to deliver tumor antigens 5.1.1.1. Carcinoembryonic ant...
متن کامل[Frontiers in Bioscience 7, d43-52, January 1, 2002] 43 IMMUNOTHERAPY OF CANCER USING HEAT SHOCK PROTEINS
1. Abstract 2. Introduction 3. Stress protein families and their immunological properties 3.1. Chaperoning properties 3.2. Peptide binding properties 3.3. Hsps interact with APCs 4. Immunogenicity of hsps 4.1. Tumor-derived hsp vaccines 4.2. Hsp-peptide based vaccines 4.3. Hsp-protein based vaccines 4.4. Hsp-based DNA vaccines 4.5. Hsp fusion protein vaccines 4.6. Cell-based vaccines 5. Improve...
متن کامل[Frontiers in Bioscience 7, d204-218, January 1, 2002] 204 RETINOIDS IN LIVER FIBROSIS AND CANCER
1. Abstract 2. Introduction 3. Retnoids and liver fibrosis 3.1. Controversy of retinoids’ effects 3.2. RA-induced TGF-β activation 3.3. Possible mechanisms to explain the controversy 3.4. Protease inhibitor 3.5. Prevention of hepatic fibrosis 3.6. Perspective 4. Retinoids and liver cancer 4.1. Chemoprevention of HCC 4.2. Retinoid refractoriness 4.3. Acyclic retinoid 4.4. Clonal deletion 4.5. Pe...
متن کامل